Juozas Gordevicius, PhD, Chief Technology Officer of VUGENE Vilnius, Lithuania, discusses  autophagy-lysosomal systems in Parkinson’s disease.

 

 

Parkinson’s disease is a neurological disorder causing unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance and coordination. Symptoms usually begin gradually and worsen over time. As the disease progresses, people may have difficulty walking and talking. They may also have mental and behavioral changes, sleep problems, depression, memory difficulties, and fatigue.

Dr. Gordevicius describes his research in autophagy-lysosomal pathways and genetic changes occurring in the appendix that may lead to Parkinson’s disease. The goal is to develop a treatment that targets these genetic changes, preventing them and subsequent neurodegenerative disorders such as Parkinson’s.

For more information on the GRIDS Symposium, click here.

To learn more about rare lysosomal storage diseases, visit https://checkrare.com/diseases/lysosomal-storage-disorders/